Following the G20 summit last week, GHTC breaks down the inclusion of research and innovation as a central pillar of the leaders' strategies, despite an overall lack of concrete action or road maps toward global change.
Philip manages the coalition’s multilateral policy analysis and advocacy work. He develops and implements outreach strategies to the various United Nations agencies and other multilateral organizations to ensure that the coalition is advocating a consistent position with all global health R&D stakeholders.
Philip has a background in global development policy and health care. Before joining GHTC, he served two years as a Senior Dedicated Advisor at the Advisory Board Company, working with hospitals and health care providers on issues surrounding burnout, patient safety, and engagement.
Prior to the Advisory Board, he managed the Alliance for Global Health and Competitiveness, a coalition of private companies and nonprofits that promote strategic investments in health care in developing and middle-income countries. As part of that work, he led lobbying efforts, helped forge new partnerships, and managed high-level roundtables to explore the challenges health decision-makers face.
He started his career at the German Marshall Fund, focusing on economic and development policy, and has worked on several political campaigns, including President Obama’s 2008 run.
Philip received his BA in Government (with a concentration in international development) from Dartmouth College. In his free time, you can usually find Philip playing soccer, rooting for the Capitals, and playing district trivia.
Blog posts written by Philip
Total of 14 blog posts
The G20 health declaration, released last week following the health ministers' annual summit, encouragingly highlighted R&D as a central pillar of pandemic preparedness. However, the declaration also stopped short of providing a clear road map to translate its ambitions into concrete measures—and more action is needed.
How the G7 can help end the current pandemic—and lay the foundation for a new health security architecture
This weekend, leaders from the G7 will come together in Cornwall, England, seeking to revive multilateralism and highlight that this forum can still play a significant role in shaping and responding to major world events. Here's a look at how G7 leaders can tackle the COVID-19 pandemic, build long-term infrastructure to prevent future health outbreaks, and seize the moment to reimagine the future of global health security.
The 74th World Health Assembly is set to convene virtually from May 24 to June 1, exhibiting the largest agenda ever with more than 72 items. Here are the top five things GHTC is watching over the course of this year’s forum.
A new hope: How the WHO Executive Board meeting signaled the need for a global pivot for global health R&D
The 148th session of the World Health Organization Executive Board came to a close last week, signaling a potential pivot point for global health. As the world continues to battle a devastating pandemic, here's a look at how 2021 could present fresh opportunities to strengthen the global R&D ecosystem.
The 73rd World Health Assembly convened virtually November 9-14 to address the ongoing COVID-19 pandemic as well as other key global health priorities. GHTC tracked the proceedings and worked with partners to weigh in on key agenda items. Here are our top takeaways from this year’s assembly.